British agency recommends against NHS use of 5 COVID treatments as not cost-effective

Britain's NICE recommends against NHS use of 5 COVID treatments as not cost-effective Britain’s agency that determines if medicines should be used in the National Health Service (NHS), has recommended stopping the use of five COVID-19 treatments, including Merck & Co's 's antiviral pill for high-risk patients, citing cost-effectiveness concerns. Maggie Fick Reuters

...The review, conducted by the National Institute for Health and Care Excellence (NICE) and published on Wednesday, is its first involving COVID-19 treatments as the pandemic enters a new phase.

...